Diabetes treatment may protect against Covid-19 mortality

997

IN a new study, the medication metformin significantly reduced the  risk of death from Covid-19 in people with diabetes. Upon analyzing data from a diverse patient population, the researchers found that individuals who had been taking metformin, a drug for type 2 diabetes, were less likely to die of Covid-19 than those not on metformin.
Their study also highlighted the fact that Black people made up a disproportionate number of those who tested positive for Covid-19.

According to the researchers, this disparity is likely due to socioeconomic factors, lack of access to healthcare, and a higher risk of exposure to SARS-CoV-2 among Black populations.

Researchers have found that people with diabetes undergoing treatment with the medication metformin are at significantly less risk of death due to Covid-19 compared with those not taking the medication.

The study, which appears in the journal Frontiers in Endocrinology, also found that African American study participants were disproportionately more likely to contract the virus than white participants.

Stay informed with live updates on the current Covid-19 outbreak and visit our coronavirus hub for more advice on prevention and treatment.

A critical area of Covid-19 research has focused on the risk factors that may make a person more likely to either get a SARS-CoV-2 infection or die from Covid-19 if they develop it.
SARS-CoV-2 is a novel coronavirus, and while it bears some similarities to other coronaviruses, there is still much that researchers are yet to uncover about how and why it affects some people more than others and how to mitigate the risks.

Studies have begun to emerge demonstrating associations between specific health issues, demographic characteristics, and the chances of contracting SARS-CoV-2 or dying from Covid-19. This research backs up early anecdotal evidence and observational studies.
The more studies that provide convincing evidence of these links, the more robust the overall findings. Meta-analyses of the available scientific literature can then demonstrate the overall picture.

In the present study, the researchers were interested in exploring the patient characteristics associated with Covid-19 in United States populations that included many Black people.

The researchers note that Black people tend to be at higher risk of key comorbidities that could make them more likely to develop Covid-19, including diabetes.

Previous articleJapan provides $19m for installation of weather surveillance radar
Next articlePakistan to rely on new blood in Karachi cricket Test against South Africa